Annual report
4578.TEDINET S100QJ0T
Period2022-01-01 → 2022-12-31
Filed2023-03-31
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Key figures · 157
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.74T | 2022-01-01 → 2022-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥1.50T | 2021-01-01 → 2021-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥1.42T | 2020-01-01 → 2020-12-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.40T | 2019-01-01 → 2019-12-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.29T | 2018-01-01 → 2018-12-31d | Cons. | Revenue IFRS (5-year summary) |
| Operating income | ¥150.3bn | 2022-01-01 → 2022-12-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥154.5bn | 2021-01-01 → 2021-12-31 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥173.0bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥163.6bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥190.0bn | 2020-01-01 → 2020-12-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥173.5bn | 2019-01-01 → 2019-12-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥109.5bn | 2018-01-01 → 2018-12-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Net income (owners) | ¥134.0bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥125.5bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥148.1bn | 2020-01-01 → 2020-12-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥127.2bn | 2019-01-01 → 2019-12-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥82.5bn | 2018-01-01 → 2018-12-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income | ¥137.4bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss IFRS |
| Net income | ¥129.2bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss IFRS |
| Total assets | ¥3.10T | at 2022-12-31 | Cons. | Assets IFRS |
| Total assets | ¥2.82T | at 2021-12-31 | Cons. | Assets IFRS |
| Total assets | ¥2.63T | at 2020-12-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥2.58T | at 2019-12-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥2.48T | at 2018-12-31d | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥840.2bn | at 2022-12-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥775.7bn | at 2021-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥2.26T | at 2022-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥2.05T | at 2021-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.88T | at 2020-12-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥2.23T | at 2022-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥2.01T | at 2021-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.85T | at 2020-12-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥1.77T | at 2019-12-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥1.70T | at 2018-12-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥471.6bn | at 2022-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥410.7bn | at 2021-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥356.9bn | at 2020-12-31d | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥334.0bn | at 2019-12-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥285.0bn | at 2018-12-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Operating cash flow | ¥211.8bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥228.9bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥232.8bn | 2020-01-01 → 2020-12-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥192.6bn | 2019-01-01 → 2019-12-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥135.8bn | 2018-01-01 → 2018-12-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Investing cash flow | −¥81.6bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥95.3bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥99.9bn | 2020-01-01 → 2020-12-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥52.3bn | 2019-01-01 → 2019-12-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥93.3bn | 2018-01-01 → 2018-12-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Financing cash flow | −¥95.5bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥95.8bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥104.9bn | 2020-01-01 → 2020-12-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥89.3bn | 2019-01-01 → 2019-12-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥89.2bn | 2018-01-01 → 2018-12-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| EPS (basic) | ¥247.01 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥231.32 | 2021-01-01 → 2021-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥273.15 | 2020-01-01 → 2020-12-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥234.55 | 2019-01-01 → 2019-12-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥152.24 | 2018-01-01 → 2018-12-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥246.99 | 2022-01-01 → 2022-12-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥231.15 | 2021-01-01 → 2021-12-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥272.35 | 2020-01-01 → 2020-12-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥231.13 | 2019-01-01 → 2019-12-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥151.26 | 2018-01-01 → 2018-12-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| Net assets per share | ¥4,101.12 | at 2022-12-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥3,707.64 | at 2021-12-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥3,415.54 | at 2020-12-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥3,257.17 | at 2019-12-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥3,145.71 | at 2018-12-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Equity ratio | 71.7% | at 2022-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 71.3% | at 2021-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 70.5% | at 2020-12-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 68.4% | at 2019-12-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 68.8% | at 2018-12-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| ROE | 6.3% | 2022-01-01 → 2022-12-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 6.5% | 2021-01-01 → 2021-12-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 8.2% | 2020-01-01 → 2020-12-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 7.3% | 2019-01-01 → 2019-12-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 4.7% | 2018-01-01 → 2018-12-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| Employees | 33,482 | at 2022-12-31 | Cons. | Number of employees |
| Employees | 33,226 | at 2021-12-31 | Cons. | Number of employees |
| Employees | 33,151 | at 2020-12-31d | Cons. | Number of employees |
| Employees | 32,992 | at 2019-12-31d | Cons. | Number of employees |
| Employees | 32,935 | at 2018-12-31d | Cons. | Number of employees |
| Revenue | ¥57.0bn | 2022-01-01 → 2022-12-31 | Standalone | Operating revenue1 |
| Revenue | ¥115.0bn | 2021-01-01 → 2021-12-31 | Standalone | Operating revenue1 |
| Revenue | ¥102.7bn | 2020-01-01 → 2020-12-31d | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥66.2bn | 2019-01-01 → 2019-12-31d | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥86.1bn | 2018-01-01 → 2018-12-31d | Standalone | Operating revenue1 (5-year summary) |
| Operating income | ¥44.3bn | 2022-01-01 → 2022-12-31 | Standalone | Operating income |
| Operating income | ¥103.4bn | 2021-01-01 → 2021-12-31 | Standalone | Operating income |
| Ordinary income | ¥46.4bn | 2022-01-01 → 2022-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥104.8bn | 2021-01-01 → 2021-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥93.5bn | 2020-01-01 → 2020-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥57.8bn | 2019-01-01 → 2019-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥79.6bn | 2018-01-01 → 2018-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥46.0bn | 2022-01-01 → 2022-12-31 | Standalone | Income before income taxes |
| Profit before tax | ¥104.8bn | 2021-01-01 → 2021-12-31 | Standalone | Income before income taxes |
| Net income | ¥47.4bn | 2022-01-01 → 2022-12-31 | Standalone | Profit loss |
| Net income | ¥106.0bn | 2021-01-01 → 2021-12-31 | Standalone | Profit loss |
| Net income | ¥94.4bn | 2020-01-01 → 2020-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥58.4bn | 2019-01-01 → 2019-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥80.0bn | 2018-01-01 → 2018-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥1.27T | at 2022-12-31 | Standalone | Assets |
| Total assets | ¥1.25T | at 2021-12-31 | Standalone | Assets |
| Total assets | ¥1.21T | at 2020-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.16T | at 2019-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.05T | at 2018-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥208.2bn | at 2022-12-31 | Standalone | Liabilities |
| Total liabilities | ¥179.3bn | at 2021-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.06T | at 2022-12-31 | Standalone | Net assets |
| Net assets / equity | ¥1.07T | at 2021-12-31 | Standalone | Net assets |
| Net assets / equity | ¥1.02T | at 2020-12-31d | Standalone | Net assets |
| Net assets / equity | ¥977.1bn | at 2019-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥970.8bn | at 2018-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥129.1bn | at 2022-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥44.8bn | at 2021-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥87.37 | 2022-01-01 → 2022-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥195.5 | 2021-01-01 → 2021-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥174.03 | 2020-01-01 → 2020-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥107.68 | 2019-01-01 → 2019-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥147.7 | 2018-01-01 → 2018-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥87.37 | 2022-01-01 → 2022-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥195.5 | 2021-01-01 → 2021-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥174.03 | 2020-01-01 → 2020-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥107.67 | 2019-01-01 → 2019-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥147.67 | 2018-01-01 → 2018-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥100 | 2022-01-01 → 2022-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥100 | 2021-01-01 → 2021-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥100 | 2020-01-01 → 2020-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥100 | 2019-01-01 → 2019-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥100 | 2018-01-01 → 2018-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,959.51 | at 2022-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,970.44 | at 2021-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,875.15 | at 2020-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,801.86 | at 2019-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,791.66 | at 2018-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 83.6% | at 2022-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 85.6% | at 2021-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 84.2% | at 2020-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 84.4% | at 2019-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 92.6% | at 2018-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 4.4% | 2022-01-01 → 2022-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.2% | 2021-01-01 → 2021-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 9.5% | 2020-01-01 → 2020-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.0% | 2019-01-01 → 2019-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.4% | 2018-01-01 → 2018-12-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 557,835,617 | at 2022-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 557,835,617 | at 2021-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 557,835,617 | at 2020-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 557,835,617 | at 2019-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 557,835,617 | at 2018-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 147 | at 2022-12-31 | Standalone | Number of employees |
| Employees | 137 | at 2021-12-31 | Standalone | Number of employees |
| Employees | 111 | at 2020-12-31d | Standalone | Number of employees |
| Employees | 104 | at 2019-12-31d | Standalone | Number of employees |
| Employees | 94 | at 2018-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 61
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2022-01-01 → 2022-12-31 | ¥10.7bn |
| Reconciling Itemsreconciling | revenue | 2022-01-01 → 2022-12-31 | −¥42.0bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-01-01 → 2022-12-31 | −¥42.0bn |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-12-31 | −¥47.9bn |
| Consumer Productsreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥3.3bn |
| Consumer Productsreportable segment | employees | at 2022-12-31 | 651 pure |
| Consumer Productsreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥35.9bn |
| Consumer Productsreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥35.9bn |
| Consumer Productsreportable segment | revenue intersegment | 2022-01-01 → 2022-12-31 | ¥26m |
| Consumer Productsreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥6.9bn |
| Nutraceuticalsreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥15.0bn |
| Nutraceuticalsreportable segment | employees | at 2022-12-31 | 8227 pure |
| Nutraceuticalsreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥437.0bn |
| Nutraceuticalsreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥437.0bn |
| Nutraceuticalsreportable segment | revenue intersegment | 2022-01-01 → 2022-12-31 | ¥32m |
| Nutraceuticalsreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥56.3bn |
| Otherreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥9.3bn |
| Otherreportable segment | employees | at 2022-12-31 | 3519 pure |
| Otherreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥169.2bn |
| Otherreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥127.3bn |
| Otherreportable segment | revenue intersegment | 2022-01-01 → 2022-12-31 | ¥42.0bn |
| Otherreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥11.9bn |
| Pharmaceuticalsreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥101.0bn |
| Pharmaceuticalsreportable segment | employees | at 2022-12-31 | 19639 pure |
| Pharmaceuticalsreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥1.14T |
| Pharmaceuticalsreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥1.14T |
| Pharmaceuticalsreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥123.1bn |
| —segment total | capex | 2022-01-01 → 2022-12-31 | ¥128.6bn |
| —segment total | employees | at 2022-12-31 | 32036 pure |
| —segment total | revenue | 2022-01-01 → 2022-12-31 | ¥1.78T |
| —segment total | revenue external | 2022-01-01 → 2022-12-31 | ¥1.74T |
| —segment total | revenue intersegment | 2022-01-01 → 2022-12-31 | ¥42.0bn |
| —segment total | segment profit | 2022-01-01 → 2022-12-31 | ¥198.3bn |
| Reconciling Itemsreconciling | capex | 2021-01-01 → 2021-12-31 | ¥17.5bn |
| Reconciling Itemsreconciling | revenue | 2021-01-01 → 2021-12-31 | −¥37.8bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-01-01 → 2021-12-31 | −¥37.8bn |
| Reconciling Itemsreconciling | segment profit | 2021-01-01 → 2021-12-31 | −¥46.2bn |
| Consumer Productsreportable segment | capex | 2021-01-01 → 2021-12-31 | ¥2.7bn |
| Consumer Productsreportable segment | revenue | 2021-01-01 → 2021-12-31 | ¥31.9bn |
| Consumer Productsreportable segment | revenue external | 2021-01-01 → 2021-12-31 | ¥31.9bn |
| Consumer Productsreportable segment | revenue intersegment | 2021-01-01 → 2021-12-31 | ¥25m |
| Consumer Productsreportable segment | segment profit | 2021-01-01 → 2021-12-31 | ¥5.3bn |
| Nutraceuticalsreportable segment | capex | 2021-01-01 → 2021-12-31 | ¥19.6bn |
| Nutraceuticalsreportable segment | revenue | 2021-01-01 → 2021-12-31 | ¥376.6bn |
| Nutraceuticalsreportable segment | revenue external | 2021-01-01 → 2021-12-31 | ¥376.6bn |
| Nutraceuticalsreportable segment | revenue intersegment | 2021-01-01 → 2021-12-31 | ¥50m |
| Nutraceuticalsreportable segment | segment profit | 2021-01-01 → 2021-12-31 | ¥46.6bn |
| Otherreportable segment | capex | 2021-01-01 → 2021-12-31 | ¥10.7bn |
| Otherreportable segment | revenue | 2021-01-01 → 2021-12-31 | ¥150.0bn |
| Otherreportable segment | revenue external | 2021-01-01 → 2021-12-31 | ¥112.3bn |
| Otherreportable segment | revenue intersegment | 2021-01-01 → 2021-12-31 | ¥37.7bn |
| Otherreportable segment | segment profit | 2021-01-01 → 2021-12-31 | ¥11.4bn |
| Pharmaceuticalsreportable segment | capex | 2021-01-01 → 2021-12-31 | ¥93.6bn |
| Pharmaceuticalsreportable segment | revenue | 2021-01-01 → 2021-12-31 | ¥977.5bn |
| Pharmaceuticalsreportable segment | revenue external | 2021-01-01 → 2021-12-31 | ¥977.5bn |
| Pharmaceuticalsreportable segment | segment profit | 2021-01-01 → 2021-12-31 | ¥137.3bn |
| —segment total | capex | 2021-01-01 → 2021-12-31 | ¥126.6bn |
| —segment total | revenue | 2021-01-01 → 2021-12-31 | ¥1.54T |
| —segment total | revenue external | 2021-01-01 → 2021-12-31 | ¥1.50T |
| —segment total | revenue intersegment | 2021-01-01 → 2021-12-31 | ¥37.8bn |
| —segment total | segment profit | 2021-01-01 → 2021-12-31 | ¥200.7bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 2,275
| Item | Context | Value | Unit |
|---|---|---|---|
| Equity attributable to owners of parent IFRS (5-year summary) | Prior1YearInstant | 2010994000000 | JPY |
| Equity attributable to owners of parent IFRS (5-year summary) | CurrentYearInstant | 2225407000000 | JPY |
| Total assets IFRS (5-year summary) | Prior4YearInstant | 2477363000000 | JPY |
| Total assets IFRS (5-year summary) | Prior3YearInstant | 2581309000000 | JPY |
| Total assets IFRS (5-year summary) | Prior2YearInstant | 2627807000000 | JPY |
| Total assets IFRS (5-year summary) | Prior1YearInstant | 2820915000000 | JPY |
| Total assets IFRS (5-year summary) | CurrentYearInstant | 3102716000000 | JPY |
| Equity to asset ratio IFRS (5-year summary) | Prior4YearInstant | 3145.71 | |
| Equity to asset ratio IFRS (5-year summary) | Prior3YearInstant | 3257.17 | |
| Equity to asset ratio IFRS (5-year summary) | Prior2YearInstant | 3415.54 | |
| Equity to asset ratio IFRS (5-year summary) | Prior1YearInstant | 3707.64 | |
| Equity to asset ratio IFRS (5-year summary) | CurrentYearInstant | 4101.12 | |
| Basic earnings loss per share IFRS (5-year summary) | Prior4YearDuration | 152.24 | |
| Basic earnings loss per share IFRS (5-year summary) | Prior3YearDuration | 234.55 | |
| Basic earnings loss per share IFRS (5-year summary) | Prior2YearDuration | 273.15 | |
| Basic earnings loss per share IFRS (5-year summary) | Prior1YearDuration | 231.32 | |
| Basic earnings loss per share IFRS (5-year summary) | CurrentYearDuration | 247.01 | |
| Diluted earnings loss per share IFRS (5-year summary) | Prior4YearDuration | 151.26 | |
| Diluted earnings loss per share IFRS (5-year summary) | Prior3YearDuration | 231.13 | |
| Diluted earnings loss per share IFRS (5-year summary) | Prior2YearDuration | 272.35 | |
| Diluted earnings loss per share IFRS (5-year summary) | Prior1YearDuration | 231.15 | |
| Diluted earnings loss per share IFRS (5-year summary) | CurrentYearDuration | 246.99 | |
| Ratio of owners equity to gross assets IFRS (5-year summary) | Prior4YearInstant | 0.688 | |
| Ratio of owners equity to gross assets IFRS (5-year summary) | Prior3YearInstant | 0.684 | |
| Ratio of owners equity to gross assets IFRS (5-year summary) | Prior2YearInstant | 0.705 | |
| Ratio of owners equity to gross assets IFRS (5-year summary) | Prior1YearInstant | 0.713 | |
| Ratio of owners equity to gross assets IFRS (5-year summary) | CurrentYearInstant | 0.717 | |
| Rate of return on equity IFRS (5-year summary) | Prior4YearDuration | 0.047 | |
| Rate of return on equity IFRS (5-year summary) | Prior3YearDuration | 0.073 | |
| Rate of return on equity IFRS (5-year summary) | Prior2YearDuration | 0.082 | |
| Rate of return on equity IFRS (5-year summary) | Prior1YearDuration | 0.065 | |
| Rate of return on equity IFRS (5-year summary) | CurrentYearDuration | 0.063 | |
| Price earnings ratio IFRS (5-year summary) | Prior4YearDuration | 29.5 | |
| Price earnings ratio IFRS (5-year summary) | Prior3YearDuration | 20.8 | |
| Price earnings ratio IFRS (5-year summary) | Prior2YearDuration | 16.2 | |
| Price earnings ratio IFRS (5-year summary) | Prior1YearDuration | 18.0 | |
| Price earnings ratio IFRS (5-year summary) | CurrentYearDuration | 17.5 | |
| Cash flows from used in operating activities IFRS (5-year summary) | Prior4YearDuration | 135821000000 | JPY |
| Cash flows from used in operating activities IFRS (5-year summary) | Prior3YearDuration | 192634000000 | JPY |
| Cash flows from used in operating activities IFRS (5-year summary) | Prior2YearDuration | 232839000000 | JPY |
| Cash flows from used in operating activities IFRS (5-year summary) | Prior1YearDuration | 228864000000 | JPY |
| Cash flows from used in operating activities IFRS (5-year summary) | CurrentYearDuration | 211848000000 | JPY |
| Cash flows from used in investing activities IFRS (5-year summary) | Prior4YearDuration | -93341000000 | JPY |
| Cash flows from used in investing activities IFRS (5-year summary) | Prior3YearDuration | -52279000000 | JPY |
| Cash flows from used in investing activities IFRS (5-year summary) | Prior2YearDuration | -99863000000 | JPY |
| Cash flows from used in investing activities IFRS (5-year summary) | Prior1YearDuration | -95288000000 | JPY |
| Cash flows from used in investing activities IFRS (5-year summary) | CurrentYearDuration | -81575000000 | JPY |
| Cash flows from used in financing activities IFRS (5-year summary) | Prior4YearDuration | -89198000000 | JPY |
| Cash flows from used in financing activities IFRS (5-year summary) | Prior3YearDuration | -89267000000 | JPY |
| Cash flows from used in financing activities IFRS (5-year summary) | Prior2YearDuration | -104932000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 21 of 21 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |